AIM
IDXX icon

Avanda Investment Management’s Idexx Laboratories IDXX Stock Holding History

Avanda Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,299
Closed -$2.68M – 36
2024
Q3 		$2.68M Sell
5,299
-5,830
-52% -$2.83M 0.52% 31
2024
Q2 		$5.42M Sell
11,129
-706
-6% -$354K 0.82% 27
2024
Q1 		$6.39M Buy
+11,835
New +$6.47M 0.86% 39

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Avanda Investment Management's IDXX Position: Q4 2024 in Review

Avanda Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 5,299 shares — an estimated $2.68M sold.

Avanda Investment Management first reported a position in IDXX in Q1 2024 and held it in 3 quarters. The position peaked at $6.39M in Q1 2024. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Avanda Investment Management reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Avanda Investment Management sold 5,299 Idexx Laboratories shares in Q4 2024, an estimated $2.68M.
  • Avanda Investment Management first reported a position in Idexx Laboratories in Q1 2024 and held it in 3 quarters.
  • Avanda Investment Management's Idexx Laboratories position peaked at $6.39M in Q1 2024.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Avanda Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.